GSP Crop Science
- P/E
- 18.35
Key Fundamentals
MicrocapFertilizers & AgrochemicalsChemicalsPrice-based figures as of · EPS basis: Consolidated · TTM
- ROCE
- 18.90%
- Debt to Equity
- 0.34
- EPS (TTM)
- ₹23.89
- Book Value
- ₹165.88
- Market Cap
- —
- P/E (TTM)
- 18.35
- P/B
- 2.64
- ROE
- 16.50%
- Dividend Yield
- 0.23%
- EBITDA
- ₹199 Cr
- 52W High
- ₹667.95
- 52W Low
- ₹328.00
- Day Range
- ₹433.00 – ₹446.80
- Volume
- 2,49,449
Peer Comparison
Commodities › Chemicals › Pesticides & Agrochemicals
| ₹529.00 | 22.09 | ₹43,728 Cr | 1.28 | 1.16% | 5.64% | 10.10% | ₹52,804 Cr | ₹2,323 Cr | |
| ₹2,187.00 | 28.48 | ₹33,248 Cr | 2.95 | 0.69% | 11.20% | 15.00% | ₹6,516 Cr | ₹1,164 Cr | |
| ₹328.10 | 28.24 | ₹15,980 Cr | 4.43 | 0.41% | 17.60% | 23.50% | ₹3,192 Cr | ₹581 Cr | |
| ₹3,249.90 | 19.95 | ₹14,602 Cr | 4.92 | 4.57% | 23.70% | 29.10% | ₹5,595 Cr | ₹733 Cr | |
| ₹677.95 | 9.77 | ₹6,015 Cr | 1.88 | 2.23% | 23.20% | 30.20% | ₹5,357 Cr | ₹626 Cr | |
| ₹942.75 | 15.83 | ₹4,217 Cr | 2.50 | 0.21% | 18.50% | 23.80% | ₹1,953 Cr | ₹268 Cr | |
| ₹189.67 | 17.23 | ₹3,734 Cr | 1.68 | 1.58% | 10.20% | 14.10% | ₹2,962 Cr | ₹214 Cr | |
| GSP Crop Science (this company) | ₹438.40 | 18.35 | ₹2,049 Cr | 2.64 | 0.23% | 16.50% | 18.90% | ₹1,526 Cr | ₹98 Cr |
| Median 8 companies | ₹603.48 | 19.15 | ₹10,309 Cr | 2.57 | 0.93% | 17.05% | 21.20% | ₹4,275 Cr | ₹604 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Key Insights
No strengths listed
Weaknesses
1- The company has delivered a poor sales growth of 7.09% over past five years.
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bearish | 10 | 5 | 4 |
| Oscillators | Bullish | 2 | 3 | 4 |
| Moving Averages | Strong Bearish | 8 | 2 | 0 |
Oscillators
Bullish
Overall
Strong Bearish
Moving Averages
Strong Bearish
Key readings
- RSI (14)
- 37.56
- Neutral
- MACD (12,26,9)
- −16.54
- Bullish
- SMA (50)
- 503.40
- Bearish
- SMA (200)
- —
- Neutral
As of
Growth Rate
From the financial statements below. 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025.
Revenue
| 5Y | +7.09% |
|---|---|
| 3Y | +8.04% |
| 1Y | +17.87% |
Net profit
| 5Y | +6.92% |
|---|---|
| 3Y | +62.84% |
| 1Y | +15.85% |
Operating cash flow
| 5Y | −12.34% |
|---|---|
| 3Y | −17.22% |
| 1Y | +55.26% |
Operating margin· change in pp
| 5Y | +0.22 pp |
|---|---|
| 3Y | +5.63 pp |
| 1Y | +0.54 pp |
Trailing twelve months: Fewer than eight quarters are reported, so there is no trailing-twelve-month figure.
Revenue by year
| Mar 2020 | ₹903 Cr |
|---|---|
| Mar 2021 | ₹1,077 Cr |
| Mar 2022 | ₹1,191 Cr |
| Mar 2023 | ₹1,203 Cr |
| Mar 2024 | ₹1,152 Cr |
| Mar 2025 | ₹1,287 Cr |
| Mar 2026 | ₹1,517 Cr |
Net profit by year
| Mar 2020 | ₹21.00 Cr |
|---|---|
| Mar 2021 | ₹68.00 Cr |
| Mar 2022 | ₹76.00 Cr |
| Mar 2023 | ₹22.00 Cr |
| Mar 2024 | ₹61.00 Cr |
| Mar 2025 | ₹82.00 Cr |
| Mar 2026 | ₹95.00 Cr |
Quarterly Results
₹ Cr| Particulars | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|
| Sales | 276 | 308 | 377 | 467 | 270 | 402 | 386 |
| Expenses | 273 | 268 | 335 | 374 | 257 | 366 | 343 |
| Operating Profit | 3 | 40 | 42 | 93 | 13 | 36 | 43 |
| OPM % | 1% | 13% | 11% | 20% | 4.9% | 9% | 11% |
| Other Income | 1 | 8 | 3 | 1 | −3 | 9 | 8 |
| Interest | 8 | 8 | 8 | 9 | 10 | 10 | 7 |
| Depreciation | 6 | 7 | 7 | 7 | 8 | 8 | 9 |
| PBT | −11 | 32 | 30 | 78 | −8 | 27 | 35 |
| Tax % | −43% | 32% | 24% | 25% | −22% | 28% | 25% |
| Net Profit | −6 | 22 | 23 | 58 | −6 | 20 | 26 |
| EPS (₹) | −1.49 | 5.81 | 6.02 | 15.2 | −1.38 | 4.4 | 5.67 |
Profit & Loss
₹ Cr| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 903 | 1,077 | 1,191 | 1,203 | 1,152 | 1,287 | 1,517 | 1,526 |
| Expenses | 832 | 949 | 1,062 | 1,125 | 1,028 | 1,137 | 1,332 | 1,341 |
| Operating Profit | 72 | 129 | 129 | 79 | 124 | 150 | 185 | 185 |
| OPM % | 8% | 12% | 11% | 7% | 11% | 12% | 12% | 12% |
| Other Income | 4 | 11 | 14 | 6 | 12 | 14 | 9 | 15 |
| Interest | 25 | 18 | 24 | 37 | 34 | 31 | 37 | 35 |
| Depreciation | 18 | 18 | 20 | 21 | 20 | 23 | 30 | 32 |
| PBT | 34 | 103 | 100 | 27 | 82 | 110 | 127 | 133 |
| Tax % | 36% | 34% | 25% | 21% | 26% | 26% | 26% | — |
| Net Profit | 21 | 68 | 76 | 22 | 61 | 82 | 95 | 99 |
| EPS (₹) | 72.32 | 230 | 256 | 77.84 | 236 | 21.38 | 21.05 | 23.89 |
| Div. Payout % | 10% | 4% | 4% | 3% | 4% | 4% | 5% | — |
Balance Sheet
₹ Cr| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Equity Capital | 29 | 29 | 29 | 27 | 26 | 39 | 47 |
| Reserves | 302 | 366 | 439 | 336 | 344 | 411 | 725 |
| Borrowings | 169 | 139 | 320 | 324 | 235 | 297 | 262 |
| Other Liabilities | 242 | 383 | 466 | 444 | 374 | 491 | 513 |
| Total Liabilities | 742 | 918 | 1,255 | 1,132 | 980 | 1,238 | 1,547 |
| Fixed Assets | 159 | 161 | 166 | 169 | 177 | 214 | 228 |
| CWIP | 7 | 9 | 11 | 16 | 51 | 50 | 67 |
| Investments | 2 | 0 | 2 | 3 | 8 | 12 | 16 |
| Other Assets | 573 | 747 | 1,076 | 945 | 745 | 961 | 1,236 |
| Total Assets | 742 | 918 | 1,255 | 1,132 | 980 | 1,238 | 1,547 |
Cash Flow
₹ Cr| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Operating | 80 | 114 | −44 | 104 | 207 | 38 | 59 |
| Investing | −24 | −19 | −42 | −47 | −19 | −80 | −74 |
| Financing | −59 | −50 | 157 | −159 | −178 | 30 | 152 |
| Net Cash Flow | −3 | 45 | 71 | −102 | 10 | −12 | 137 |
| Free Cash Flow | 64 | 91 | −93 | 70 | 179 | −34 | −17 |
| CFO/OP | 132 | 112 | −23 | 169 | 180 | 45 | 56 |
Ratios
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Debtor Days | 113 | 99 | 125 | 126 | 103 | 112 | 133 |
| Inventory Days | 119 | 153 | 182 | 155 | 111 | 189 | 146 |
| Days Payable | 113 | 162 | 165 | 156 | 114 | 176 | 158 |
| Cash Conversion Cycle | 120 | 90 | 142 | 125 | 99 | 126 | 121 |
| Working Capital Days | 54 | 51 | 72 | 56 | 39 | 50 | 68 |
| ROCE % | — | 23% | 18% | 8% | 17% | 21% | 19% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view GSP Crop Science insights
60 extracted metrics across FY20–FY27.
Documents
- Q1 FY27 concall · Aug 2026Transcript PPT Recording
- Concall · Apr 2026Transcript PPT Recording
- 29 Apr 2026
- 31 Jan 2025
- 27 Jan 2025
- 3 Nov 2023
- 27 Sep 2022
- General announcements 15 Oct 2026
- General announcements 12 Oct 2026
- General announcements 22 Sep 2026
Frequently Asked Questions about GSP Crop Science
What does GSP Crop Science Ltd do?
Where is GSP Crop Science Ltd (GSPCROP) listed?
Which sector does GSP Crop Science Ltd belong to?
What is the PE ratio of GSP Crop Science Ltd?
What is the 52-week high and low of GSP Crop Science Ltd?
Does GSP Crop Science Ltd pay dividends?
What is the Return on Equity (ROE) of GSP Crop Science Ltd?
Company Information
Company mejorly focusing on fungiside and insecticide and related pesticide
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/GSPCROP.md for GSP Crop Science Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.